Compare BridgeBio Pharma Inc (BBIO) vs Transocean Ltd (RIG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BridgeBio Pharma Inc vs Transocean Ltd — how do they compare? BridgeBio Pharma Inc trades at $84.09 (market cap $16.27B), while Transocean Ltd trades at $5.31 (market cap $5.94B). The key difference: BridgeBio Pharma Inc is far larger — about 2.7× Transocean Ltd's market cap, and BridgeBio Pharma Inc is trading nearer its 52-week high, Transocean Ltd nearer its low. Which is the better fit depends on your goals.
| BBIO | RIG | |
|---|---|---|
Market Cap | $16.27B | $5.94B |
Sector | Health | Technology |
52-Week High | $90.17 | $7.58 |
52-Week Low | $44.81 | $2.55 |
Enterprise Value | $17.82B | $10.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Read more on BBIO →About Transocean Ltd
Transocean Ltd. is a leading international provider of offshore contract drilling services for oil and gas wells. The company operates one of the world's most versatile fleets of mobile offshore drilling units, including ultra-deepwater drillships and harsh environment semi-submersibles. RIG's services are essential to energy exploration and production companies seeking to access deepwater and challenging reserves globally.
Read more on RIG →
